Guardant Health

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Guardant Health 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GH

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. 

CEO
Helmy Eltoukhy
CEOHelmy Eltoukhy
Employees
2,506
Employees2,506
Headquarters
Palo Alto, California
HeadquartersPalo Alto, California
Founded
2011
Founded2011
Employees
2,506
Employees2,506

GH Key Statistics

Market cap
12.56B
Market cap12.56B
Price-Earnings ratio
-28.14
Price-Earnings ratio-28.14
Dividend yield
Dividend yield
Average volume
2.06M
Average volume2.06M
High today
$98.50
High today$98.50
Low today
$89.07
Low today$89.07
Open price
$96.57
Open price$96.57
Volume
3.19M
Volume3.19M
52 Week high
$120.74
52 Week high$120.74
52 Week low
$36.36
52 Week low$36.36

Stock Snapshot

Guardant Health(GH) stock is priced at $96.00, giving the company a market capitalization of 12.56B. It carries a P/E multiple of -28.14.

On 2026-05-10, Guardant Health(GH) stock traded between a low of $89.07 and a high of $98.50. Shares are currently priced at $96.00, which is +7.8% above the low and -2.5% below the high.

The Guardant Health(GH)'s current trading volume is 3.19M, compared to an average daily volume of 2.06M.

During the past year, Guardant Health(GH) stock moved between $36.36 at its lowest and $120.74 at its peak.

During the past year, Guardant Health(GH) stock moved between $36.36 at its lowest and $120.74 at its peak.

GH News

TipRanks 2d
Guardant Health reports Q1 adjusted EPS (45c), consensus (47c)

Reports Q1 revenue $301.7M, consensus $279.06M. “Our first-quarter revenue increased 48% year over year, reflecting strong momentum across the Guardant portfoli...

Analyst ratings

92%

of 25 ratings
Buy
92%
Hold
8%
Sell
0%

People also own

Based on the portfolios of people who own GH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.